Literature DB >> 11696384

Affinity maturation in trout: clonal dominance of high affinity antibodies late in the immune response.

Stephen L Kaattari1, Haili L Zhang, Ing W Khor, Ilsa M Kaattari, David A Shapiro.   

Abstract

The ability of an animal to develop a highly specific antibody response through affinity maturation has been considered an integral part of the adaptive immune response. However, much of the literature dealing with teleostean antibody responses suggests that little or no affinity maturation may occur within these taxa. As trout antibodies are similar to multimeric mammalian IgM, it has been reasoned that affinity maturational shifts in intrinsic affinity might be similarly small. Such small increases in affinity can, however, lead to potentially great avidity changes for multimeric antibodies. We therefore employed a partition-based immunoassay that permits the dissection of a single antiserum into discrete, affinity-based antibody subpopulations. Such partitioning assays provide for enhanced sensitivity and resolution of these affinity subpopulations over that which can be obtained by fluorescence quenching or equilibrium dialysis. Through the use of the partition-based immunoassay, we were able to detect a consistent increase in affinity within trout anti-TNP antisera. Furthermore, it was determined that trout are capable of generating new, higher affinity antibodies relatively late in the antibody response, which then come into dominance. Such evidence suggests that either somatic mutation does occur or that a unique form of affinity-based regulation of antibody expression is employed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11696384     DOI: 10.1016/s0145-305x(01)00064-7

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  20 in total

Review 1.  Perspectives on antigen presenting cells in zebrafish.

Authors:  Kanako L Lewis; Natasha Del Cid; David Traver
Journal:  Dev Comp Immunol       Date:  2014-03-29       Impact factor: 3.636

2.  Evolution of transcriptional enhancers in the immunoglobulin heavy-chain gene: functional characteristics of the zebrafish Emu3' enhancer.

Authors:  Kristofor K Ellestad; Brad G Magor
Journal:  Immunogenetics       Date:  2005-03-09       Impact factor: 2.846

3.  Biochemical Regulatory Features of Activation-Induced Cytidine Deaminase Remain Conserved from Lampreys to Humans.

Authors:  Emma M Quinlan; Justin J King; Chris T Amemiya; Ellen Hsu; Mani Larijani
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

Review 4.  Immunological control of fish diseases.

Authors:  Bergljot Magnadottir
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

Review 5.  Evolution of B cell immunity.

Authors:  David Parra; Fumio Takizawa; J Oriol Sunyer
Journal:  Annu Rev Anim Biosci       Date:  2013-01       Impact factor: 8.923

Review 6.  Evolutionary and functional relationships of B cells from fish and mammals: insights into their novel roles in phagocytosis and presentation of particulate antigen.

Authors:  J Oriol Sunyer
Journal:  Infect Disord Drug Targets       Date:  2012-06

Review 7.  Fishing for mammalian paradigms in the teleost immune system.

Authors:  J Oriol Sunyer
Journal:  Nat Immunol       Date:  2013-04       Impact factor: 25.606

8.  Evaluation of a time efficient immunization strategy for anti-PAH antibody development.

Authors:  Xin Li; Stephen L Kaattari; Mary Ann Vogelbein; Michael A Unger
Journal:  J Immunoassay Immunochem       Date:  2016

Review 9.  Unique Features of Fish Immune Repertoires: Particularities of Adaptive Immunity Within the Largest Group of Vertebrates.

Authors:  Susana Magadan; Oriol J Sunyer; Pierre Boudinot
Journal:  Results Probl Cell Differ       Date:  2015

10.  Teleost fish mount complex clonal IgM and IgT responses in spleen upon systemic viral infection.

Authors:  Rosario Castro; Luc Jouneau; Hang-Phuong Pham; Olivier Bouchez; Véronique Giudicelli; Marie-Paule Lefranc; Edwige Quillet; Abdenour Benmansour; Frédéric Cazals; Adrien Six; Simon Fillatreau; Oriol Sunyer; Pierre Boudinot
Journal:  PLoS Pathog       Date:  2013-01-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.